Not available
Quote | Eli Lilly and Company (NYSE:LLY)
Last: | $733.51 |
---|---|
Change Percent: | 0.19% |
Open: | $723.48 |
Close: | $733.51 |
High: | $737.45 |
Low: | $721 |
Volume: | 1,998,800 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
News | Eli Lilly and Company (NYSE:LLY)
2024-04-26 15:00:06 ET More on the markets SPY: The 'Value' From Equities Is Historically Low SPY: The Setup Looks Extremely Bearish Be Greedy When Others Are Fearful, Even If They Are Fearful For A Good Reason BofA watched clients retract $2B last week as th...
2024-04-26 14:04:32 ET This week was one of the heaviest in terms of companies that reported their first quarter earnings. Here is a recap of a few popular names that have reported their results.... Read the full article on Seeking Alpha For further details see: More than ha...
Message Board Posts | Eli Lilly and Company (NYSE:LLY)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $LLY News Article - Cramer dubs Lilly's Alzheimer's drug a 'holy grail' after today's d | whytestocks | investorshangout | 05/03/2023 7:05:51 PM |
whytestocks: $LLY News Article - Lilly to Participate in Bank of America Securities 2023 Healthcare | whytestocks | investorshangout | 05/03/2023 4:40:54 PM |
whytestocks: $LLY News Article - Lilly's Donanemab Significantly Slowed Cognitive and Functional Dec | whytestocks | investorshangout | 05/03/2023 4:35:50 PM |
whytestocks: $LLY News Article - Lilly Declares Second-Quarter 2023 Dividend | whytestocks | investorshangout | 05/01/2023 6:40:48 PM |
whytestocks: $LLY News Article - Eli Lilly and Company (NYSE: LLY) is a Leading Gainer in 4/21 Morni | whytestocks | investorshangout | 04/21/2023 6:50:46 PM |
News, Short Squeeze, Breakout and More Instantly...
Eli Lilly and Company Company Name:
LLY Stock Symbol:
NYSE Market:
Jim Cramer, the host of CNBC’s “Mad Money,” has outlined the key events that investors should keep an eye on in the upcoming week...
The Senate Committee on Health, Education, Labor, and Pensions is reportedly scrutinizing Novo Nordisk A/S (NYSE:NVO) ‘s pric...
2024-04-24 06:40:00 ET Eli Lilly 's (NYSE: LLY) Zepbound has shown it has what it takes to become a blockbuster. The weight-loss drug, following regulatory approval late last year, brought in $175 million in revenue in just its first few weeks on the market. Doctors and their patien...